Tyra Biosciences, Inc.
TYRA
$10.09
$0.020.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -54.72% | -12.01% | -13.54% | -40.91% | -53.13% |
| Total Depreciation and Amortization | 17.21% | 41.18% | 53.01% | 41.57% | 46.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 92.52% | 87.78% | 36.35% | 0.59% | 18.62% |
| Change in Net Operating Assets | 56.02% | -94.92% | 105.08% | 455.73% | -1,316.98% |
| Cash from Operations | -15.57% | -44.77% | -4.39% | -6.69% | -123.70% |
| Capital Expenditure | 89.71% | 99.00% | 37.35% | -993.02% | -231.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 75.96% | 104.84% | -- | -- | -- |
| Cash from Investing | 77.20% | 104.82% | 26,072.29% | -337,088.37% | 44,180.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.91% | 117.90% | 59.10% | 68.65% | 53,220.21% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.91% | 117.90% | 59.10% | 0.81% | 53,175.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -95.54% | 92.43% | 126.26% | -1,567.48% | 2,164.34% |